Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH ALEMBIC PHARMA PROCTER & GAMBLE HEALTH/
ALEMBIC PHARMA
 
P/E (TTM) x 34.4 32.1 107.1% View Chart
P/BV x 10.5 4.4 238.4% View Chart
Dividend Yield % 2.0 0.8 247.5%  

Financials

 PROCTER & GAMBLE HEALTH   ALEMBIC PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
ALEMBIC PHARMA
Mar-23
PROCTER & GAMBLE HEALTH/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs5,366792 677.2%   
Low Rs3,883463 838.1%   
Sales per share (Unadj.) Rs740.7287.6 257.6%  
Earnings per share (Unadj.) Rs138.217.4 794.5%  
Cash flow per share (Unadj.) Rs155.231.4 494.0%  
Dividends per share (Unadj.) Rs95.008.00 1,187.5%  
Avg Dividend yield %2.11.3 161.2%  
Book value per share (Unadj.) Rs447.6222.3 201.3%  
Shares outstanding (eoy) m16.60196.56 8.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.22.2 286.0%   
Avg P/E ratio x33.536.1 92.7%  
P/CF ratio (eoy) x29.820.0 149.1%  
Price / Book Value ratio x10.32.8 365.9%  
Dividend payout %68.746.0 149.5%   
Avg Mkt Cap Rs m76,761123,402 62.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,06211,691 17.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,29656,526 21.8%  
Other income Rs m18430 604.9%   
Total revenues Rs m12,48056,557 22.1%   
Gross profit Rs m3,2476,772 47.9%  
Depreciation Rs m2812,754 10.2%   
Interest Rs m8502 1.5%   
Profit before tax Rs m3,1423,546 88.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m847126 671.9%   
Profit after tax Rs m2,2953,420 67.1%  
Gross profit margin %26.412.0 220.4%  
Effective tax rate %27.03.6 758.3%   
Net profit margin %18.76.1 308.5%  
BALANCE SHEET DATA
Current assets Rs m11,71329,139 40.2%   
Current liabilities Rs m6,79116,408 41.4%   
Net working cap to sales %40.022.5 177.7%  
Current ratio x1.71.8 97.1%  
Inventory Days Days26310 2,711.7%  
Debtors Days Days3437 5,083.3%  
Net fixed assets Rs m10,61731,498 33.7%   
Share capital Rs m166393 42.2%   
"Free" reserves Rs m7,26543,312 16.8%   
Net worth Rs m7,43143,705 17.0%   
Long term debt Rs m00-   
Total assets Rs m22,33060,637 36.8%  
Interest coverage x409.18.1 5,070.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 59.1%   
Return on assets %10.36.5 159.4%  
Return on equity %30.97.8 394.7%  
Return on capital %42.49.3 457.7%  
Exports to sales %046.4 0.0%   
Imports to sales %13.112.1 107.8%   
Exports (fob) Rs mNA26,210 0.0%   
Imports (cif) Rs m1,6056,846 23.5%   
Fx inflow Rs m1,46526,210 5.6%   
Fx outflow Rs m1,6056,846 23.5%   
Net fx Rs m-14019,364 -0.7%   
CASH FLOW
From Operations Rs m2,3607,240 32.6%  
From Investments Rs m-215-4,476 4.8%  
From Financial Activity Rs m-985-2,620 37.6%  
Net Cashflow Rs m1,160144 806.3%  

Share Holding

Indian Promoters % 0.0 69.1 -  
Foreign collaborators % 51.8 0.5 10,160.8%  
Indian inst/Mut Fund % 20.3 19.0 106.5%  
FIIs % 7.6 4.5 168.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 30.4 158.5%  
Shareholders   56,730 85,212 66.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs ALEMBIC PHARMA Share Price Performance

Period Procter & Gamble Health ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day -0.69% -0.45% 1.18%
1-Month -7.59% -4.58% -0.75%
1-Year -3.15% 104.81% 61.82%
3-Year CAGR -9.16% 0.79% 18.16%
5-Year CAGR 5.72% 13.50% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.